Research graph
References from In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
10.1002/ijc.29210 · 2015 · External reference
Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy
10.1159/000181865 · 2008 · External reference
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
10.3322/caac.21161 · 2012 · External reference
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes
10.1016/j.surg.2006.06.028 · 2007 · External reference
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
10.1016/s0016-5085(03)00689-9 · 2003 · External reference
Management of hepatocellular carcinoma
10.1002/hep.20933 · 2005 · External reference
Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma
10.1016/j.jamcollsurg.2009.12.026 · 2010 · External reference
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
10.1136/gut.48.2.251 · 2001 · External reference
Hepatocellular carcinoma in cirrhosis: incidence and risk factors
10.1053/j.gastro.2004.09.014 · 2004 · External reference
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance
10.1053/j.gastro.2003.12.049 · 2004 · External reference
Role of epidermal growth factor receptor in breast cancer
10.1007/s10549-012-2289-9 · 2012 · External reference
Targeting EGFR in pancreatic cancer treatment
10.2174/138945012800564158 · 2012 · External reference
Epidermal growth factor receptor mutations in lung adenocarcinoma
10.1038/labinvest.2013.147 · 2014 · External reference
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
10.1054/bjoc.2000.1580 · 2001 · External reference
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
10.1002/hep.20538 · 2005 · External reference
Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma
10.1111/j.1600-0463.2006.apm_323.x · 2006 · External reference
Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma
10.1309/wf10qaaed3pp93bh · 2008 · External reference
Epidermal growth factor receptor (EGFR) crosstalks in liver cancer
10.3390/cancers3022444 · 2011 · External reference
Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma
10.1038/labinvest.2010.161 · 2011 · External reference
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma
10.1016/j.jhep.2004.08.024 · 2004 · External reference
Analysis of epidermal growth factor receptor expression in hepatocellular carcinoma: a comparision of fluorescence in situ hybridization and immunochemistry
2014 · External reference
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model
2003 · External reference
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression
10.1158/0008-5472.can-07-0575 · 2007 · External reference
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
10.1038/nm.2341 · 2011 · External reference
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis
10.1200/jco.2003.11.069 · 2003 · External reference
EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
10.1038/modpathol.3800438 · 2005 · External reference
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer
10.1158/0008-5472.can-07-5200 · 2008 · External reference
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
10.1038/sj.bjc.6603566 · 2007 · External reference
EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus
10.1002/ijc.21454 · 2006 · External reference
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes
10.1155/2013/759057 · 2013 · External reference
EGFR overexpressed in colonic neoplasia can be detected on wide-field endoscopic imaging
10.1038/ctg.2015.28 · 2015 · External reference
Molecular targeting with peptides or peptide-polymer conjugates: just a question of size?
2005 · External reference
Peptides and peptide hormones for molecular imaging and disease diagnosis
10.1021/cr900361p · 2010 · External reference
Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements
10.7863/jum.2010.29.6.891 · 2010 · External reference
Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models
10.1158/0008-5472.can-05-0440 · 2005 · External reference
HYPR-spectral photoacoustic CT for preclinical imaging
2009 · External reference
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
10.1016/s0168-3659(99)00248-5 · 2000 · External reference
Exploiting the enhanced permeability and retention effect for tumor targeting
10.1016/j.drudis.2006.07.005 · 2006 · External reference
Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging
10.1002/smll.200800714 · 2008 · External reference
Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer
2011 · External reference
Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging
10.1038/nbt1220 · 2006 · External reference
Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain
10.1021/nl049126a · 2004 · External reference
Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography
10.1088/0957-4484/20/39/395102 · 2009 · External reference
Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance
10.1016/j.tibtech.2011.01.006 · 2011 · External reference
Activatable oligomerizable imaging agents for photoacoustic imaging of furin-like activity in living subjects
10.1021/ja4010078 · 2013 · External reference
Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting
10.1016/j.biomaterials.2009.08.045 · 2009 · External reference
Ultrahigh sensitivity carbon nanotube agents for photoacoustic molecular imaging in living mice
10.1021/nl100890d · 2010 · External reference
Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma
10.1158/0008-5472.can-10-4557 · 2011 · External reference
Simultaneous molecular and hypoxia imaging of brain tumors in vivo using spectroscopic photoacoustic tomography
10.1109/jproc.2007.913515 · 2008 · External reference
Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging
10.1063/1.2777127 · 2007 · External reference
Photoacoustic imaging of multiple targets using gold nanorods
10.1109/tuffc.2007.435 · 2007 · External reference
In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods
10.1364/oe.16.018605 · 2008 · External reference
Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents
10.1038/nnano.2009.231 · 2009 · External reference
Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer
10.1021/nl802929u · 2009 · External reference
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
2014 · External reference
Monoclonal antibody pharmacokinetics and pharmacodynamics
10.1038/clpt.2008.170 · 2008 · External reference
10.4161/mabs.2.3.11641 · 2010 · Admitted local publication
EGFR and cancer prognosis
10.1016/s0959-8049(01)00231-3 · 2001 · External reference
On sensitivity of molecular specific photoacoustic imaging using plasmonic gold nanoparticles
2009 · External reference
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts
2003 · External reference
Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia
10.1593/neo.09188 · 2009 · External reference
Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography
10.1158/0008-5472.can-14-1656 · 2014 · External reference
Non-invasive molecular profiling of cancer using photoacoustic imaging of functionalized gold nanorods
2014 · External reference
Multiplex photoacoustic molecular imaging using targeted silica-coated gold nanorods
10.1364/boe.2.001828 · 2011 · External reference
Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging
10.1021/nn204100n · 2012 · External reference
Biomedical applications of photoacoustic imaging with exogenous contrast agents
10.1007/s10439-011-0449-4 · 2012 · External reference
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles
2003 · External reference
Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles
10.1073/pnas.0813019106 · 2009 · External reference
Elements of scientific visualization in basic neuroscience research
10.1641/0006-3568(2004)054[1127:eosvib]2.0.co;2 · 2004 · External reference
Screening and quantification of the tumor microenvironment with micro-ultrasound and photoacoustic imaging
10.1038/nmeth.f.381 · 2015 · External reference
Molecular SPECT imaging: an overview
10.1155/2011/796025 · 2011 · External reference
Photoacoustic imaging enhanced by indocyanine green-conjugated single-wall carbon nanotubes
10.1117/1.jbo.18.9.096006 · 2013 · External reference
Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine
10.1021/jp057170o · 2006 · External reference
Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064nm
10.1021/nn302782y · 2012 · External reference
Nanoparticles for photoacoustic imaging
10.1002/wnan.42 · 2009 · External reference
Carbon nanotubes as photoacoustic molecular imaging agents in living mice
10.1038/nnano.2008.231 · 2008 · External reference
Semiconducting polymer nanoprobe for in vivo imaging of reactive oxygen and nitrogen species
10.1002/anie.201303420 · 2013 · External reference
Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice
10.1038/nnano.2013.302 · 2014 · External reference
Conjugated polymer nanoparticles for photoacoustic vascular imaging
10.1039/c3py01587d · 2014 · External reference
Diketopyrrolopyrrole-based semiconducting polymer nanoparticles for in vivo photoacoustic imaging
10.1002/adma.201502285 · 2015 · External reference
10.2217/17435889.1.4.473 · 2006 · Admitted local publication
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice
10.1038/nnano.2006.170 · 2007 · External reference
Acute toxicity and pharmacokinetics of 13nm-sized PEG-coated gold nanoparticles
10.1016/j.taap.2008.12.023 · 2009 · External reference
Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant
10.1021/nl803487r · 2009 · External reference
PEG-modified gold nanorods with a stealth character for in vivo applications
10.1016/j.jconrel.2006.06.017 · 2006 · External reference
Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects
10.2174/138161210791920496 · 2010 · External reference
Renal clearance of quantum dots
10.1038/nbt1340 · 2007 · External reference
Clearance pathways and tumor targeting of imaging nanoparticles
10.1021/acsnano.5b01320 · 2015 · External reference
Nanomedicines for cancer therapy: an update of FDA approved and those under various stages of development
2014 · External reference
Nanoparticles for biomedical imaging: fundamentals of clinical translation
10.2310/7290.2010.00031 · 2010 · External reference
Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer
10.2174/1381612811319250009 · 2013 · External reference
Toxicity of organic fluorophores used in molecular imaging: literature review
10.2310/7290.2009.00031 · 2009 · External reference
HCC heterogeneity: molecular pathogenesis and clinical implications
2009 · External reference
EpCAM-positive hepatocellular carcinoma cells are tumor-Initiating cells with stem/progenitor cell features
10.1053/j.gastro.2008.12.004 · 2009 · External reference
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
10.1111/j.1582-4934.2008.00364.x · 2009 · External reference
A new model of patient tumor-derived breast cancer xenografts for preclinical assays
10.1158/1078-0432.ccr-07-0078 · 2007 · External reference
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy
10.1158/1078-0432.ccr-09-2878 · 2010 · External reference
Patient-derived tumour xenografts as models for oncology drug development
10.1038/nrclinonc.2012.61 · 2012 · External reference
Xenografts of human hepatocellular carcinoma: a useful model for testing drugs
10.1158/1078-0432.ccr-05-2568 · 2006 · External reference
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases induces growth inhibition in mouse models of human hepatocellular carcinoma
10.1158/1078-0432.ccr-08-0509 · 2008 · External reference
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
10.1016/j.jhep.2009.10.008 · 2010 · External reference
Family of enhanced photoacoustic imaging agents for high-sensitivity and multiplexing studies in living mice
10.1021/nn204352r · 2012 · External reference
